A long term carcinogenicity study in rats revealed a slightly increased incidence of hepatocellular adenomas in females in the high dose (200 mg/kg). The drug is non-genotoxic. The clinical relevance of these abnormalities is unknown.
Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.
By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy. For more information on cookies, see our cookie policy.